Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

BACKGROUND: Intravenous iron is widely used to control anemia in dialysis patients and limits costs related to erythropoiesis-stimulating agents (ESA). Current guidelines do not clearly set upper limits for serum ferritin (SF) and transferrin saturation (TSAT). International surveys such as the Dial...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, N. O., Jay, N., Cridlig, J., Rostoker, G., Frimat, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358046/
https://www.ncbi.nlm.nih.gov/pubmed/28320343
http://dx.doi.org/10.1186/s12882-017-0513-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358046/
https://www.ncbi.nlm.nih.gov/pubmed/28320343
http://dx.doi.org/10.1186/s12882-017-0513-x

Ejemplares similares